These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 26539739)

  • 41. The Chronic Kidney Disease Epidemiology Collaboration cystatin C (CKD-EPI-CysC) equation has an independent prognostic value for overall survival in newly diagnosed patients with symptomatic multiple myeloma; is it time to change from MDRD to CKD-EPI-CysC equations?
    Terpos E; Christoulas D; Kastritis E; Katodritou E; Pouli A; Michalis E; Papassotiriou I; Dimopoulos MA;
    Eur J Haematol; 2013 Oct; 91(4):347-55. PubMed ID: 23829647
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Circulating subsets and CD4(+)CD25(+) regulatory T cell function in chronic inflammatory demyelinating polyradiculoneuropathy.
    Sanvito L; Makowska A; Gregson N; Nemni R; Hughes RA
    Autoimmunity; 2009; 42(8):667-77. PubMed ID: 19886739
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Decrease in intrahepatic CD56+ lymphocytes in gastric and colorectal cancer patients with liver metastases.
    Gulubova M; Manolova I; Kyurkchiev D; Julianov A; Altunkova I
    APMIS; 2009 Dec; 117(12):870-9. PubMed ID: 20078551
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Achieving chronic kidney disease treatment targets in renal transplant recipients: results from a cross-sectional study in Spain.
    Marcén R; del Castillo D; Capdevila L; Fernandez-Fresnedo G; Rodrigo E; Cantarell C; Fernández-Rodriguez A; López-Oliva MO; Camps J; Aljama P; Ortuño J; Arias M
    Transplantation; 2009 May; 87(9):1340-6. PubMed ID: 19424034
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evidence of a selective depletion of a CD16+ CD56+ CD8+ natural killer cell subset during HIV infection.
    Lucia B; Jennings C; Cauda R; Ortona L; Landay AL
    Cytometry; 1995 Mar; 22(1):10-5. PubMed ID: 7587727
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Analysis of serum T-lymphocyte subsets and NK cell activity in patients with squamous cell carcinoma of pharynx and larynx].
    Chen W; Wang X; Tao R
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Dec; 25(24):1105-7. PubMed ID: 22390028
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biological variability of lymphocyte subsets of human adults' blood.
    Tosato F; Bernardi D; Sanzari MC; Pantano G; Plebani M
    Clin Chim Acta; 2013 Sep; 424():159-63. PubMed ID: 23770423
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Uraemia-induced immune senescence and clinical outcomes in chronic kidney disease patients.
    Crépin T; Legendre M; Carron C; Vachey C; Courivaud C; Rebibou JM; Ferrand C; Laheurte C; Vauchy C; Gaiffe E; Saas P; Ducloux D; Bamoulid J
    Nephrol Dial Transplant; 2020 Apr; 35(4):624-632. PubMed ID: 30202981
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decreased B1 and B2 Lymphocytes Are Associated With Mortality in Elderly Patients With Chronic Kidney Diseases.
    Lin J; Tang W; Liu W; Yu F; Wu Y; Fang X; Zhou M; Hao W; Hu W
    Front Med (Lausanne); 2020; 7():75. PubMed ID: 32266271
    [No Abstract]   [Full Text] [Related]  

  • 50. Potential Use of Autologous Renal Cells from Diseased Kidneys for the Treatment of Renal Failure.
    George SK; Abolbashari M; Jackson JD; Aboushwareb T; Atala A; Yoo JJ
    PLoS One; 2016; 11(10):e0164997. PubMed ID: 27776163
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of Yishenjiangzhuo granules on immunity and bone metabolism in patients with stage 3-4 chronic kidney disease.
    Zheng J; Lin Y; Huang L; Chen C; Zheng X; Wu X; Liu C
    J Tradit Chin Med; 2013 Oct; 33(5):620-5. PubMed ID: 24660585
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Natural Killer Cells in Kidney Health and Disease.
    Turner JE; Rickassel C; Healy H; Kassianos AJ
    Front Immunol; 2019; 10():587. PubMed ID: 30972076
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of renal function and immune system cells in elderly individuals from São Paulo City.
    Teixeira D; Longo-Maugeri LM; Duarte YA; Lebrão ML; Bueno V
    Clinics (Sao Paulo); 2013 Jan; 68(1):39-44. PubMed ID: 23420155
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Emergence of T cell immunosenescence in diabetic chronic kidney disease.
    Chiu YL; Tsai WC; Hung RW; Chen IY; Shu KH; Pan SY; Yang FJ; Ting TT; Jiang JY; Peng YS; Chuang YF
    Immun Ageing; 2020; 17():31. PubMed ID: 33088331
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deep immune profiling of patients with renal impairment unveils distinct immunotypes associated with disease severity.
    Wu IW; Wu YL; Yang HY; Hsu CK; Chang LC; Twu YC; Chang YL; Chung WH; Yang CW; Hsieh WP; Su SC
    Clin Kidney J; 2023 Jan; 16(1):78-89. PubMed ID: 36726440
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel Immune Cell Subsets Exhibit Different Associations With Vascular Outcomes in Chronic Kidney Disease Patients-Identifying Potential Biomarkers.
    Rodríguez-Carrio J; Carrillo-López N; Ulloa C; Martín-Carro B; Rodríguez-Suárez C; Naves-Díaz M; Sánchez-Álvarez E; Rodríguez-García M; Arcidiacono MV; Fernández-Mariño B; Cannata-Andía JB; Suárez A; Dusso AS
    Front Med (Lausanne); 2021; 8():618286. PubMed ID: 34113627
    [No Abstract]   [Full Text] [Related]  

  • 57. Changes of Intestinal Flora and Lymphocyte Subsets in Patients with Chronic Renal Failure.
    Lv Y; Ren G; Ren X
    Evid Based Complement Alternat Med; 2021; 2021():4288739. PubMed ID: 34764999
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term B cell depletion associates with regeneration of kidney function.
    Fleig SV; Konen FF; Schröder C; Schmitz J; Gingele S; Bräsen JH; Lovric S; Schmidt BMW; Haller H; Skripuletz T; von Vietinghoff S
    Immun Inflamm Dis; 2021 Dec; 9(4):1479-1488. PubMed ID: 34324242
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical and hematological data to group different chronic kidney disease patients: A practical approach to establish different groups of patients.
    Péterle VB; Souza JO; Busato FO; Eutrópio FJ; da Costa GAP; Olivieri DN; Tadokoro CE
    J Clin Lab Anal; 2018 Jun; 32(5):e22377. PubMed ID: 29314251
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of immune response in initiation and progression of chronic kidney disease.
    Shahbazi M; Smailnejad Ganji K; Mirzakhani M; Mohammadnia-Afrouzi M; Akbari R
    Iran J Kidney Dis; 2019 Sep; 13(5):283-299. PubMed ID: 31705744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.